Eurofins | GenomeWeb

Eurofins

The lab was opened earlier this year as the company's central genomics lab in North America, offering various genomic services such as DNA sequencing.

The company is hoping to find a niche among customers who want the quality of high-throughput oligonucleotide synthesis but smaller order volumes.

Living DNA can break down the origins of a customer’s ancestry into 21 distinct regions within Britain alone, as well as across 80 different worldwide populations.

The company's subsidiary Viracor-IBT can now run the real time, reverse transcriptase-PCR assay for patients meeting clinical or epidemiological criteria for Zika.

The combined company, which will retain the Eurofins BioDiagnostics name, will offer a range of analytical testing services to the ag-bio market.

Agilent will offer its SureVector cloning kits through Eurofins and will supply components for cloning services performed by Eurofins.

The facility will be the firm's central genomics lab in North America, handling custom DNA and RNA production, synthetic gene synthesis, and genomic services.

The new joint venture will be called EGL Genetic Diagnostics.

The Belgium-based testing firm believes acquiring the university laboratory will strengthen its position in specialty clinical diagnostic testing.

Pages

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.